Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections?

Critical Care

Volumn 9, Issue 3, 2005, Pages 257-258

  Wertheim, Heiman F L ^a   Vos, Margreet C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

METICILLIN; PLACEBO; PSEUDOMONIC ACID; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; BACTERIUM CONTAMINATION; CLINICAL TRIAL; CRITICAL ILLNESS; DISINFECTION; DRUG EFFICACY; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; INTENSIVE CARE UNIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; PERSONAL HYGIENE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION;

ADMINISTRATION, INTRANASAL; ANTI-BACTERIAL AGENTS; CROSS INFECTION; HUMANS; INTENSIVE CARE UNITS; METHICILLIN RESISTANCE; MUPIROCIN; STAPHYLOCOCCAL INFECTIONS;

EID: 20444376145     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc3720     Document Type: Article

References (16)

1. Muller AA, Talon D, Potier A, Belle A, Cappelier G, Bertrand X: Use of intranasal mupirocin to prevent MRSA infection in intensive care units. Crit Care 2005, 9:R246-R250.
2. Pujol M, Pena C, Pallares R, Ariza J, Ayats J, Dominguez MA, Gudiol F: Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996, 100:509-516.
3. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y: Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003, 36:53-59.
4. Perl TM, Cullen JJ, Wenzel RP, Zimmerman MB, Pfaller MA, Sheppard D, Twombley J, French PP, Herwaldt LA: Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002, 346:1871-1877.
5. Kalmeijer MD, Coertjens H, Van Nieuwland-Bollen PM, Bogaers-Hofman D, De Baere GA, Stuurman A, Van Belkum A, Kluytmans JA: Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 2002, 35:353-358.
6. Wertheim HF, Vos MC, Ott A, Voss A, Kluytmans JA, Vandenbroucke-Grauls CM, Meester MH, van Keulen PH, Verbrugh HA: Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study. Ann Intern Med 2004, 140:419-425.
7. Boelaert JR, De Smedt RA, De Baere YA, Godard CA, Matthys EG, Schurgers ML, Daneels RF, Gordts BZ, Van Landuyt HW: The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. Nephrol Dial Transplant 1989, 4:278-281.
8. Corbella X, Dominguez MA, Pujol M, Ayats J, Sendra M, Pallares R, Ariza J, Gudiol F: Staphylococcus aureus nasal carriage as a marker for subsequent staphylococcal infections in intensive care unit patients. Eur J Clin Microbiol Infect Dis 1997, 16:351-357.
9. Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA, van Keulen PH, Vandenbroucke-Grauls CM, Meester MH, Verbrugh HA: Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004, 364:703-705.
10. Nijssen S, Bonten MJ, Weinstein RA: Are active microbiological surveillance and subsequent isolation needed to prevent the spread of methicillin-resistant Staphylococcus aureus? Clin Infect Dis 2005, 40:405-409.
11. Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, Taylor L, Hayman S, Cookson B, Shaw S, et al.: Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 2005, 365:295-304.
12. Voss A: Preventing the spread of MRSA. BMJ 2004, 329:521.
13. Miller D, Urdaneta V, Weltman A: Public Health Dispatch: vancomycin-resistant Staphylococcus aureus - Pennsylvania, 2002. MMWR 2002, 51:902.
14. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown WJ, et al.: Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003, 348:1342-1347.
15. Kacica M, McDonald LC: Brief report: vancomycin-resistant Staphylococcus aureus - New York, 2004. MMWR 2004, 53:322-323.
16. Cookson BD: The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother 1998, 41:11-18.